The selective toxicity of TRAIL to tumor cells is mainly due to the presence of TRAIL receptors (TRAIL receptor 1/death receptor (DR) 4 and TRAIL receptor 2/DR5) containing death domains on the membrane of tumor cells [4,5,6,7]. The gene discussed is TNFRSF10A; the disease is neoplasm.